The autosomal dominant optic atrophy (ADOA) treatment market is experiencing steady expansion, driven by growing disease awareness, advancements in diagnosis, and breakthrough therapies from key ...

The autosomal dominant optic atrophy treatment market is experiencing significant expansion, driven by increasing disease awareness, rising prevalence, and R&D in precision medicine from key ...

A research team from the Medical University of Vienna and the Medical University of Graz has discovered a previously unknown genetic cause of hereditary optic atrophy, a degenerative disease of the ...

– Data provide insights that informed the Phase 1 study of STK-002 as a potential disease-modifying medicine for ADOA, including disease etiology, progression and clinical assessments – – ADOA is a ...

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression ...

Please provide your email address to receive an email when new articles are posted on . Band optic atrophy is described as a horizontal band of optic disc pallor, often associated with a contralateral ...

A novel treatment for Leber's Hereditary Optic Neuropathy (LHON), a rare genetic disease that can lead to sudden loss of vision, has been approved for NHS patients following a successful clinical ...

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression ...

TOKYO — Sotos’ syndrome, an extremely rare genetic disorder characterized by excessive growth before and after birth, may be associated with optic disc pallor and retinal atrophy. A case report of a ...